PLSE 10-Q: SEC filing
Pulse Biosciences
Filed with the SEC on · accession 0001437749-26-035267
PLSE filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -7.0% by the first close after the filing.
Summary of the filing
Pulse Biosciences filed its quarterly report on Form 10-Q for the quarter ended September 30, 2026, accompanied by the standard CEO certification under Section 302 of the Sarbanes-Oxley Act.
Key details
How PLSE stock reacted
Close before
$57.06
Nov 4, 2026
First close after
-6.99%
$53.07
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PLSE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PLSE?
Click hereFrequently asked questions
What did PLSE file with the SEC on Nov 5, 2026?
PLSE filed a 10-Q (SEC filing). Pulse Biosciences filed its quarterly report on Form 10-Q for the quarter ended September 30, 2026, accompanied by the standard CEO certification under Section 302 of the Sarbanes-Oxley Act.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did PLSE stock react to this filing?
PLSE closed at $57.06 before the filing and $53.07 on Nov 5, 2026 (-6.99%).
Other PLSE SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · Contract winOct 14, 2026
- 8-K · Fda approvalOct 7, 2026
- 8-K · Fda approvalSep 15, 2026
- 424B5 · Secondary offeringSep 15, 2026
- 8-K · Secondary offeringSep 15, 2026
- 8-K · Guidance raiseAug 6, 2026
- 424B5 · Secondary offeringAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Secondary offeringAug 6, 2026
Get alerts when PLSE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days